ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.01B
AUM Growth
+$394M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
251
New
Increased
Reduced
Closed

Top Buys

1
+$27.6M
2
+$20.5M
3
+$17.4M
4
ETNB
89bio
ETNB
+$12.6M
5
JANX icon
Janux Therapeutics
JANX
+$7.04M

Top Sells

1
+$105M
2
+$14.6M
3
+$7.97M
4
SAGE
Sage Therapeutics
SAGE
+$6.58M
5
VERV
Verve Therapeutics
VERV
+$5.27M

Sector Composition

1 Healthcare 87.7%
2 Financials 1.74%
3 Communication Services 0.1%
4 Consumer Discretionary 0.1%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOS
226
DELISTED
iTeos Therapeutics
ITOS
– –
-26,937
IOVA icon
227
Iovance Biotherapeutics
IOVA
$1.5B
– –
0
INZY
228
DELISTED
Inozyme Pharma
INZY
– –
-37,161
INMB icon
229
INmune Bio
INMB
$35.4M
– –
0
EPIX
230
DELISTED
ESSA Pharma
EPIX
– –
-50,000
ENGN icon
231
enGene Holdings
ENGN
$670M
– –
-27,787
EMCGW
232
DELISTED
Embrace Change Acquisition Corp Warrants
EMCGW
– –
-18,000
EMCGR
233
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
– –
-13,144
ELDN icon
234
Eledon Pharmaceuticals
ELDN
$212M
– –
-16,900
DSGN icon
235
Design Therapeutics
DSGN
$583M
– –
-42,408
CRMD icon
236
CorMedix
CRMD
$568M
– –
-175,000
CNTB
237
Connect Biopharma Holdings
CNTB
$140M
– –
-10,300
CLBR
238
DELISTED
Colombier Acquisition Corp II
CLBR
– –
-10,000
CASI
239
DELISTED
CASI Pharmaceuticals
CASI
– –
-44,120
BPMC
240
DELISTED
Blueprint Medicines
BPMC
– –
-15,000
BOLT icon
241
Bolt Biotherapeutics
BOLT
$8.7M
– –
-10,823
BCAB icon
242
BioAtla
BCAB
$15.1M
– –
-170,506
AVXL icon
243
Anavex Life Sciences
AVXL
$420M
– –
-16,221
AUPH icon
244
Aurinia Pharmaceuticals
AUPH
$1.87B
– –
-10,000
ARGX icon
245
argenx
ARGX
$46.8B
– –
-1,759
ARDX icon
246
Ardelyx
ARDX
$1.57B
– –
-915,130
APGE icon
247
Apogee Therapeutics
APGE
$4.85B
– –
-18,070
ALEC icon
248
Alector
ALEC
$241M
– –
-1,723,526
ALDX icon
249
Aldeyra Therapeutics
ALDX
$338M
– –
-249,920
6 7 8 9
10